<DOC>
	<DOCNO>NCT00564018</DOCNO>
	<brief_summary>To determine whether use long-acting insulin analog time diagnosis , instead intermediate-acting insulin , affect rate loss body 's ability make insulin child newly diagnose type 1 diabetes .</brief_summary>
	<brief_title>Duration The Honeymoon Phase Type 1 Diabetes : A Comparison Insulins Detemir , Glargine NPH</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Newly diagnose type 1 diabetes within 1 week diagnosis Age 6 18 year Care provide Children 's Medical Center , Dallas Actual treatment oral drug influence beta cell function blood glucose level ( e.g . oral hypoglycemic agent ) Actual treatment drug influence insulin sensitivity ( e.g . Metformin , systemic steroid ) Significant concomitant disease likely interfere glucose metabolism ( child active bacterial infection time diagnosis must cure prior entry ) Expected poor compliance Pregnancy Any condition judgement investigator may potentially harmful patient</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>type 1 diabetes , basal-bolus , honeymoon , C-peptide</keyword>
</DOC>